188 related articles for article (PubMed ID: 37821971)
1. Metabolomic analysis for asymptomatic hyperuricemia and gout based on a combination of dried blood spot sampling and mass spectrometry technology.
Liu S; Liu Y; Wu X; Liu Z
J Orthop Surg Res; 2023 Oct; 18(1):769. PubMed ID: 37821971
[TBL] [Abstract][Full Text] [Related]
2. Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout.
Shen X; Wang C; Liang N; Liu Z; Li X; Zhu ZJ; Merriman TR; Dalbeth N; Terkeltaub R; Li C; Yin H
Arthritis Rheumatol; 2021 Sep; 73(9):1738-1748. PubMed ID: 33760368
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics approach by
Zhang Y; Zhang H; Chang D; Guo F; Pan H; Yang Y
Arthritis Res Ther; 2018 Jun; 20(1):111. PubMed ID: 29871692
[TBL] [Abstract][Full Text] [Related]
4. The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics.
Wu X; You C
PeerJ; 2023; 11():e14554. PubMed ID: 36632144
[TBL] [Abstract][Full Text] [Related]
5. Plasma profiling of amino acids distinguishes acute gout from asymptomatic hyperuricemia.
Luo Y; Wang L; Liu XY; Chen X; Song YX; Li XH; Jiang C; Peng A; Liu JY
Amino Acids; 2018 Nov; 50(11):1539-1548. PubMed ID: 30073607
[TBL] [Abstract][Full Text] [Related]
6. A metabonomic study to explore potential markers of asymptomatic hyperuricemia and acute gouty arthritis.
Wang W; Kou J; Zhang M; Wang T; Li W; Wang Y; Xie Q; Wei M
J Orthop Surg Res; 2023 Feb; 18(1):96. PubMed ID: 36782295
[TBL] [Abstract][Full Text] [Related]
7. Identification of the urine and serum metabolomics signature of gout.
Huang Y; Xiao M; Ou J; Lv Q; Wei Q; Chen Z; Wu J; Tu L; Jiang Y; Zhang X; Qi J; Qiu M; Cao S; Gu J
Rheumatology (Oxford); 2020 Oct; 59(10):2960-2969. PubMed ID: 32134107
[TBL] [Abstract][Full Text] [Related]
8. Plasma and Urinary Metabolomic Analysis of Gout and Asymptomatic Hyperuricemia and Profiling of Potential Biomarkers: A Pilot Study.
Ohashi Y; Ooyama H; Makinoshima H; Takada T; Matsuo H; Ichida K
Biomedicines; 2024 Jan; 12(2):. PubMed ID: 38397902
[TBL] [Abstract][Full Text] [Related]
9. Untargeted metabolomics reveal the therapeutic effects of Ermiao wan categorized formulas on rats with hyperuricemia.
Shan B; Chen T; Huang B; Liu Y; Chen J
J Ethnopharmacol; 2021 Dec; 281():114545. PubMed ID: 34419610
[TBL] [Abstract][Full Text] [Related]
10. Metabolite biomarker discovery for human gastric cancer using dried blood spot mass spectrometry metabolomic approach.
Wu X; Ao H; Gao H; Zhu Z
Sci Rep; 2022 Aug; 12(1):14632. PubMed ID: 36030300
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares.
Wang M; Li R; Qi H; Pang L; Cui L; Liu Z; Lu J; Wang R; Hu S; Liang N; Tao Y; Dalbeth N; Merriman TR; Terkeltaub R; Yin H; Li C
Arthritis Rheumatol; 2023 Dec; 75(12):2252-2264. PubMed ID: 37390372
[TBL] [Abstract][Full Text] [Related]
12. Plasma Metabolic Profiling Analysis of Gout Party on Acute Gout Arthritis Rats Based on UHPLC-Q-TOF/MS Combined with Multivariate Statistical Analysis.
Wang Y; Bi C; Pang W; Liu Y; Yuan Y; Zhao H; Zhang T; Zhao Y; Li Y
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731809
[TBL] [Abstract][Full Text] [Related]
13. [Hyperuricemia and gout: diagnosis and therapy].
Tausche AK; Unger S; Richter K; Wunderlich C; Grässler J; Roch B; Schröder HE
Internist (Berl); 2006 May; 47(5):509-20; quiz 521. PubMed ID: 16586130
[TBL] [Abstract][Full Text] [Related]
14. NMR spectroscopy based metabolomics confirms the aggravation of metabolic disorder in metabolic syndrome combined with hyperuricemia.
Zhang Y; Zhang H; Rong S; Bian C; Yang Y; Pan H
Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2449-2457. PubMed ID: 34154888
[TBL] [Abstract][Full Text] [Related]
15. A metabolomics strategy to identify potential biomarkers associated with human laryngeal cancer based on dried blood spot mass spectrometry approach.
Wu X; Liu Y; Ao H; Yang P; Zhu Z
Medicine (Baltimore); 2022 Feb; 101(8):e28820. PubMed ID: 35212275
[TBL] [Abstract][Full Text] [Related]
16. Study on chemical constituents of herbal formula Er Miao Wan and GC-MS based metabolomics approach to evaluate its therapeutic effects on hyperuricemic rats.
Huang B; Hu X; Wang J; Li P; Chen J
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1118-1119():101-108. PubMed ID: 31030102
[TBL] [Abstract][Full Text] [Related]
17. Targeted and non-targeted metabolomics uncovering the effects of Er-Miao-Wan formula on rats with hyperuricemia.
Gu C; Hu X; Shan B; Wu X; Chen J
J Pharm Biomed Anal; 2023 Mar; 226():115246. PubMed ID: 36731256
[TBL] [Abstract][Full Text] [Related]
18. Study on the diagnosis of gout with xanthine and hypoxanthine.
Wang Y; Deng M; Deng B; Ye L; Fei X; Huang Z
J Clin Lab Anal; 2019 Jun; 33(5):e22868. PubMed ID: 30803031
[TBL] [Abstract][Full Text] [Related]
19. Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes.
Guma M; Dadpey B; Coras R; Mikuls TR; Hamilton B; Quehenberger O; Thorisdottir H; Bittleman D; Lauro K; Reilly SM; Liu-Bryan R; Terkeltaub R
Arthritis Res Ther; 2022 Jul; 24(1):175. PubMed ID: 35879786
[TBL] [Abstract][Full Text] [Related]
20. Serum metabolic profiling analysis of gout patients based on UPLC-Q-TOF/MS.
Zhong Z; Huang Y; Huang Q; Zheng S; Huang Z; Deng W; Li T
Clin Chim Acta; 2021 Apr; 515():52-60. PubMed ID: 33388309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
